ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AGL Angle Plc

10.00
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Angle Plc LSE:AGL London Ordinary Share GB0034330679 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 10.00 9.50 10.50 10.00 10.00 10.00 187,307 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Business Services, Nec 2.19M -20.13M -0.0624 -1.60 32.26M
Angle Plc is listed in the Business Services sector of the London Stock Exchange with ticker AGL. The last closing price for Angle was 10p. Over the last year, Angle shares have traded in a share price range of 7.25p to 37.50p.

Angle currently has 322,641,668 shares in issue. The market capitalisation of Angle is £32.26 million. Angle has a price to earnings ratio (PE ratio) of -1.60.

Angle Share Discussion Threads

Showing 33351 to 33373 of 33375 messages
Chat Pages: 1335  1334  1333  1332  1331  1330  1329  1328  1327  1326  1325  1324  Older
DateSubjectAuthorDiscuss
30/12/2024
01:55
They have not done the molecular analysis, see above and below from the half yearly:

“ Prostate and ovarian cancer studies

Recruitment of participants for the Company's prostate cancer study (DOMINO) and ovarian cancer study (EMBER2) has completed. DOMINO resulted in the collection of >400 blood samples from 100 prostate cancer patients whilst EMBER2 collected >1,400 blood samples from 400 ovarian cancer patients. The blood tubes drawn from each patient have been processed using the Parsortix system and the cell harvest stored for future molecular analysis. ”

sicilian_kan
29/12/2024
21:51
So results of domino study could drop anytime now?
seball
29/12/2024
20:14
Thanks for the clarification, Bermuda.
Can you explain the lack of progress with DOMINO.

tbow112
29/12/2024
17:51
tbow112 - that isn't the Domino study. It was a separate study that a particular researcher at Solaris was interested in working on. It was terminated after only recruiting 9 patients. As others have pointed out, the Domino study has fully recruited 100 patients.
bermudashorts
29/12/2024
14:58
Has anyone read the paper arising from the original Barts study which apparently suggested that there was room for improvement with Parsortix ?
tbow112
29/12/2024
14:54
This seems to be the original plan for DOMINO but the trial has since been terminated.
tbow112
29/12/2024
11:47
From the half year report

"Prostate and ovarian cancer studies

Recruitment of participants for the Company's prostate cancer study (DOMINO) and ovarian cancer study (EMBER2) has completed. DOMINO resulted in the collection of >400 blood samples from 100 prostate cancer patients whilst EMBER2 collected >1,400 blood samples from 400 ovarian cancer patients. The blood tubes drawn from each patient have been processed using the Parsortix system and the cell harvest stored for future molecular analysis."

No mention of Solaris in the RNS



sent from my iPhone

kryptonsnake
29/12/2024
11:40
From Angle website

"The first patients were enrolled into this study in Q1, 2023, with headline results expected in 2024. Compelling data from the DOMINO study could form the basis of a laboratory developed test (LDT) which ANGLE would offer from its clinical laboratories in the US and the UK.

MidLantic Urology, an affiliate of Solaris Health Partners (Solaris), is one of the largest providers of specialist urology services in the US. The Solaris Health network encompasses more than 500 clinical urology providers across 179 locations and nine states treating ~730,000 patients annually."



Sent from my iPhone

kryptonsnake
29/12/2024
11:24
- partnership established with Solaris Health, a major United States urology group to evaluate the Parsortix system in prostate cancer
- clinical study now underway and expected to complete during 2023

htrocka2
29/12/2024
10:28
Does that not suggest that something has gone significantly wrong with the Solaris project ? Initial results were expected in 2023.
Have I missed some announcement ?

tbow112
27/12/2024
21:48
According to Andrew they are. I think they are in the process of selecting the most appropriate downstream analytical system. I understand they have the samples in storage.
jelenko
27/12/2024
21:05
Is there any evidence that Angle continues to work with Solaris ?
tbow112
27/12/2024
14:36
Associated Urologists of North Carolina Has Joined Solaris Health

"AUNC brings to Solaris the skills and talents of 30 providers who care for over 40,000 unique patients each year. The addition of AUNC means that Solaris now aligns the skills and talents of over 730 providers who annually care for over one million unique patients located in 14 states."

gooosed
27/12/2024
13:47
Give it a few months I'll be selling for huge profits



sent from my iPhone

kryptonsnake
27/12/2024
13:43
If you were as smart as me, you would have also sold at a huge profit....
willfy
27/12/2024
13:31
If I made near on 300% profit on a stock I wouldn't feel the need to visit the board almost yearly to berate the management

Perhaps you should look to buy in and repeat that win

But I doubt you a smart enough



sent from my iPhone

kryptonsnake
27/12/2024
11:24
Probably 698 masquerading. Sad
muffster
27/12/2024
11:06
I am not gloating, I have family and friends who are still sadly invested here.Parsortix is an amazing product, it could and should be an absolute game changer when it comes to Cancer diagnosis and capturing CTC.But in my opinion due to AN negligence, it still years away from been used to its full potential.How many life's could have been saved, if only the board had a clear and precise way of getting the product mainstream...
willfy
27/12/2024
10:50
Surely you must have something better to do than coming onto this board to gloat? Go and enjoy the rest of the holidays.
robizm
27/12/2024
10:40
My average was 19p, bought in about 14 yrs ago, so nice profit for me, whilst I imagine your sitting on a Huge loss, but still defending how the company are handling things.Was very active on this BB for many years, though I'm guessing most of the LTH have also bailed out, hopefully with a profit t
willfy
27/12/2024
10:06
I'm guessing you paid a lot more than 80p for your shares

Your posting history is just you turning up on this board every year to say you sold at 80p

Nobody gives a flying fu*k



sent from my iPhone

kryptonsnake
27/12/2024
08:33
Sold out at around 80p mark a few yrs ago, so massive profit whilst you're probably nursing huge losses on your investment, so who's the muppet now !Share price is currently below 10p, so wasn't far out with my prediction.Angle needs a total clear out of the board, AN is clearly out of his depth
willfy
25/12/2024
12:12
Merry Christmas to all.
lairddavid
Chat Pages: 1335  1334  1333  1332  1331  1330  1329  1328  1327  1326  1325  1324  Older